Source link : https://newshealth.biz/health-news/tezepelumab-cuts-oral-corticosteroid-use-in-severe-asthma/
(MedPage Today) — Most patients with severe asthma substantially reduced or even discontinued oral corticosteroid use with addition of tezepelumab (Tezspire) in the single-arm WAYFINDER trial. At both 28 and 52 weeks, 88.9% of patients dropped… Source link : https://www.medpagetoday.com/meetingcoverage/ats/115672 Author : Publish date : 2025-05-20 16:38:00 Copyright for syndicated content belongs to the linked […]
The post Tezepelumab Cuts Oral Corticosteroid Use in Severe Asthma first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-20 16:38:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8